Favresse, J.; Gillot, C.; Di Chiaro, L.; Eucher, C.; Elsen, M.; Van Eeckhoudt, S.; David, C.; Morimont, L.; Dogné, J.-M.; Douxfils, J.
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses 2021, 13, 1364.
https://doi.org/10.3390/v13071364
AMA Style
Favresse J, Gillot C, Di Chiaro L, Eucher C, Elsen M, Van Eeckhoudt S, David C, Morimont L, Dogné J-M, Douxfils J.
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses. 2021; 13(7):1364.
https://doi.org/10.3390/v13071364
Chicago/Turabian Style
Favresse, Julien, Constant Gillot, Laura Di Chiaro, Christine Eucher, Marc Elsen, Sandrine Van Eeckhoudt, Clara David, Laure Morimont, Jean-Michel Dogné, and Jonathan Douxfils.
2021. "Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2" Viruses 13, no. 7: 1364.
https://doi.org/10.3390/v13071364
APA Style
Favresse, J., Gillot, C., Di Chiaro, L., Eucher, C., Elsen, M., Van Eeckhoudt, S., David, C., Morimont, L., Dogné, J.-M., & Douxfils, J.
(2021). Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses, 13(7), 1364.
https://doi.org/10.3390/v13071364